摘要
目的检测急性脑梗死患者发病急性期与恢复期血浆D-二聚体(D-D)、纤维蛋白原降解产物(FDP)及C反应蛋白(CRP)的水平,探讨3项指标对于急性脑梗死的辅助诊疗价值。方法分别检测36例脑梗死患者发病急性期与恢复期以及50例健康体检者的血浆D-D、FDP及CRP水平。结果脑梗死急性期患者血浆D-D、FDP及CRP水平与恢复期患者及对照组血浆D-D、FDP及CRP水平存在显著差异;并且脑梗死患者急性期血浆D-D检测阳性率显著高于血浆FDP检测阳性率。结论血浆D-D、FDP与CRP的实验室联合检测对判断急性脑梗死的发生、严重程度及疗效观察有一定临床意义,值得基层医院推广应用。
Objective To measure the plasma levels of D-dimer（D-D） ,fibrin degradation production（FDP）and C reactive protein（CRP）in patients with acute cerebral infarction in acute period and convalescence, and discuss the assistant diagnosis value of the three plasma indicators in patient with acute cerebral infarction. Methods The plasma levels of D-D,FDP and CRP in 36 patients with acute cerebral infarction in acute period and convalescence and 50 health people were tested. Results The plasma levels of D-D,FDP and CRP of patients with acute cerebral infarction in acute period were distinctly higher than that of convalescence and health control group. For acute cerebral infarc tion patients in acute period, the positive rate of D-D in plasma was distinctly higher than the counterpart of FDP in plasma. Conclusion The combined detection of D-D,FDP and CRP of plasma in clinical laboratory can be used to estimate the occurrence of acute cerebral infarction and inflammatory condition, which is especially adapt for application in small hospitals.
出处
《检验医学与临床》
CAS
2011年第10期1185-1186,共2页
Laboratory Medicine and Clinic
